Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ NDUFB9 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA520922
Description
A suggested positive control is human liver tissue lysate. PA5-20922 can be used with blocking peptide PEP-1036.
LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.
Specifications
NDUFB9 | |
Polyclonal | |
Unconjugated | |
Ndufb9 | |
1190008J14Rik; B22; CI-B22; complex I B22 subunit; complex I-B22; EGK_19260; LYR motif-containing protein 3; LYRM3; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9; NADH:ubiquinone oxidoreductase subunit B9; NADH-ubiquinone oxidoreductase B22 subunit; NDUFB9; UQOR22 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
299954, 4715, 66218 | |
Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C | |
Liquid |
Immunohistochemistry, Western Blot | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
Q9CQJ8, Q9Y6M9 | |
Ndufb9 | |
A 17 amino acid peptide near the carboxy terminus of human LYRM3. | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction